The drug-eluting stents (DES) market is witnessing a dynamic transformation as cardiovascular diseases (CVDs) continue to rank among the leading causes of mortality worldwide. According to recent industry insights, the global drug-eluting stents market was valued at US$ 7.7 Bn in 2024 and is projected to reach US$ 14.2 Bn by 2035, expanding at a compound annual growth rate (CAGR) of 5.7% during ..